Chee Kong Choo's most recent trade in CytoMed Therapeutics Ltd was a trade of 112,000 Ordinary Shares, no par value per share done at an average price of $1.1 . Disclosure was reported to the exchange on June 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CytoMed Therapeutics Ltd | Chee Kong Choo | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 08 Jun 2026 | 112,000 | 430,324 | - | 1.1 | 128,778 | Ordinary Shares, no par value per share |